A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...